Clinical trial · Interventional
A Prospective Comparative Study Between Oncoplastic Breast Surgery and Standard Wide Local Excision
A Prospective Comparative Study Between Oncoplastic Breast Surgery and Standard Wide Local Excision:Margin Length and Patient Satisfaction
NCT02923635CI-TRIAL-00024133completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to asses the oncological safety of oncoplastic breast surgery, and its impact on patient satisfaction.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| oncoplastic breast surgery. | Procedure | — | UNRESOLVED |
| Standard wide local excision. | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Standard Wide Local Excision group
- description
- Group A (35 patients) have standard curative conservative breast surgery without integration of plastic techniques .
- interventionNames
- Procedure: Standard wide local excision.
- type
- ACTIVE_COMPARATOR
- label
- Oncoplastic group
- description
- Group B(35 patients) have curative oncoplastic surgery in which plastic techniques integrated with oncological procedures
- interventionNames
- Procedure: oncoplastic breast surgery.
Primary outcomes (1)
- measure
- Margins in all specimens measured in millimeters
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with macromastia in oncoplastic group. * Tumors \>20% of breast volume in oncoplastic group. * Young patients in oncoplastic group * Tumors in medial or central quadrants in oncoplastic group Exclusion Criteria: * Patients \>60 years. * Patients with co-morbidities in oncoplastic group. * Tumors \>20% of breast volume in standard group. * Tumors in medial or central quadrants in standard group
References
Publications (0)
Data not yet available
No reference posted for this study.